Aleor Dermaceuticals Ltd Receives EIR For Its Formulation Facility At Karkhadi

Aleor Dermaceuticals Ltd. Joint Venture between Alembic Pharmaceuticals Ltd (Alembic) and Orbicular Pharmaceutical Technologies Pvt. Ltd. (Orbicular), has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for the inspection carried out by them at Aleor’s Formulation Facility at Karakhadi, Gujarat, India during the period from 16th September, 2019 to 20th September, 2019.

Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.554 as compared to the previous close of Rs. 545.65. The total number of shares traded during the day was 1628 in over 166 trades.

The stock hit an intraday high of Rs. 555 and intraday low of 546.4. The net turnover during the day was Rs. 897030.-Equity Bulls